News

The study outlines Onco-STS, a web-based laboratory information management system for sample and analysis tracking in oncogenomic experiments.

A research team writes in Cell Metabolism that they have uncovered a clue to how bacteria may promote some colon cancers.

NIH-funded research finds therapeutic hypothermia no more effective than normal temperature control.

NIH-funded pilot study provides a new resource about variants across the human genome.

Acquisition adds novel candidates including Pre-IND candidate for fibrotic diseases to MorphoSys's growing proprietary portfolio.

Researchers to precisely target, cut, remove and replace DNA in a living cell to improve rice.

Schizophrenia affects millions of people worldwide but the cause of its wide-ranging symptoms remains largely unknown.

Approximately 50 percent of patients with diabetes suffer from nerve damage, or neuropathy. No cure exists, and the most effective treatment, keeping blood sugar in control, only slows neuropathy. A new study in the Journal of Neurophysiology, however, introduces a new alternative, omega-3 fatty acids found in fish oil.

Early studies show promise for alternative type of anesthetic.

The company, a leader in the development of RNA interference (RNAi) therapeutics, presented preclinical data demonstrating the feasibility of its proprietary DsiRNA-EX Conjugate-mediated delivery technology.